Navigation Links
AHIP Commends IOM for Recommending Comparative Effectiveness Program
Date:1/24/2008

WASHINGTON, Jan. 24 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans, today issued a statement on the Institute of Medicine's (IOM) recommendation to create a national program that would evaluate the effectiveness of healthcare products and services:

(Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO )

"Patients deserve to know not only what medical treatments work, but which treatments work best. With new treatments and technologies introduced each day, providers need a dependable and trusted source of information that provides useful guidance on treatment options available. A national entity to compare the effectiveness of new technologies will help the nation evaluate what works, what doesn't and how best to allocate resources.

"Last year, health insurance plans proposed the establishment of a national entity to evaluate new and existing health care treatments and technologies. Today's recommendation by the IOM adds further momentum toward this objective."

To learn more about AHIP's proposal to improve the quality and safety of care, please visit http://www.ahip.org.

Providing Health Benefits for Over 200 Million Americans.


'/>"/>
SOURCE America's Health Insurance Plans
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
2. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
3. State Director of Health Commends Ohio Dentists and ODH Bureau of Oral Health for Serving Those in Need
4. AIDS Action Council Commends Senator Edwards for Endorsing a National HIV/AIDS Strategy
5. American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act
6. American College of Physicians recommends flu vaccination for health-care workers
7. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
8. FDA Panel Recommends Ban on Cold Medicines for Kids
9. AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies
10. CHPA Commends Senator Biden on Legislation Aimed at Curbing Medicine-Abuse Trend
11. National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners ... as their value increases in the healthcare workforce, according to a survey recently ... boards, career fairs, and candidate leads to healthcare employers of physicians and advanced ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Israel , March 28, 2017 Emosis ... This new business entity, Emosis Ltd, headquartered in Tel ... of novel assays complementing the mother company existing technology platform and ... and sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. ...
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: